EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China

Xin Zeng, Chuan Yin, Chun Yan Sun, Cui Hua Lu, Shou Song Zhao, Xiao Hong Gao, Dong Feng Chen, Liang Zhi Wen, Shi De Lin, Ping Yang, Qian Hua Zhang, Yu Juan Guan und 11 weitere

Journal of Digestive Diseases · 2023-02 · 24 (2) · 122-132

DOI: 10.1111/1751-2980.13171 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Digestive Diseases, online erschienen am 11.05.2023. Verfasst von Xin Zeng und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Hepatic Encephalopathy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Medical Innovation Research Project of Shanghai Science and Technology Commission, Outstanding Youth Medical Talents Project of Shanghai "Rising Stars of Medical Talent" Youth Development Program, Pilot Talent Plan of Shanghai East Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to investigate the prevalence of covert hepatic encephalopathy (CHE) in cirrhotic patients in China and its risk factors.

Methods

A multicenter prospective observational study was conducted from January 2021 to March 2022 at 16 medical centers across China to investigate the risk factors of CHE and establish a prediction model for CHE episodes.

Results

A total of 528 patients were enrolled in the study. Based on both the psychometric hepatic encephalopathy score and Stroop test results, the prevalence of CHE was 50.4% (266/528), and the consistency between these two tests was 68.9%. Multivariate analysis showed that age (odds ratio [OR] 1.043, 95% confidence interval [CI] 1.022–1.063, P < 0.001), duration of education (OR 0.891, 95% CI 0.832–0.954, P = 0.001), comorbidities of cardiovascular diseases, hypertension, cerebral apoplexy or diabetes mellitus (OR 2.072, 95% CI 1.370–3.133, P < 0.001), Child–Pugh score (OR 1.142, 95% CI 1.029–1.465, P = 0.025), and blood urea nitrogen concentration (OR 1.126, 95% CI 1.038–1.221, P = 0.004) were associated with CHE episodes. According to the Chronic Liver Disease Questionnaire, CHE patients had lower scores for abdominal symptoms and systemic symptoms ( P < 0.001), indicating a poor health‐related quality of life. Based on a stepwise Cox regression hazard model, we established a nomogram for determining the probabilities of CHE episodes, and the area under the receiver operating characteristic curve was 0.733 (95% CI 0.679–0.788) and 0.713 (95% CI 0.628–0.797) in the training and validation cohorts.

Conclusions

CHE is a common complication of cirrhosis in China. Large‐scale studies with long‐term follow‐up are needed to determine the natural history of Chinese CHE patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic EncephalopathyHumansQuality of LifePrevalenceRisk FactorsLiver CirrhosisChina

Stichwörter der Autor:innen

Stroop testcognitive dysfunctioncovert hepatic encephalopathyhealth-related quality of lifepsychometric hepatic encephalopathy score

Autor:innen und Institutionen

  • Department of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Department of Gastroenterology, Changzheng Hospital, Navy Medical University, Shanghai, China.
  • Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.
  • Department of Infectious Diseases, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, China.
  • Department of Infectious Diseases, Affiliated Hospital of Yan'an University, Yan'an, Shaanxi Province, China.
  • Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.

ORCID-Profile: Yong Lin, Wei Fen Xie

Förderung

  • Medical Innovation Research Project of Shanghai Science and Technology Commission
  • Outstanding Youth Medical Talents Project of Shanghai "Rising Stars of Medical Talent" Youth Development Program
  • Pilot Talent Plan of Shanghai East Hospital
  • Talent Plan of Shanghai Municipal Health Commission for Academic Leader

Zitieren

APA

Zeng, X., Yin, C., Sun, C. Y., Lu, C. H., Zhao, S. S., Gao, X. H., Chen, D. F., Wen, L. Z., Lin, S., Yang, P., Zhang, Q. H., Guan, Y. J., Zhang, Y., Ren, S. Q., Cai, D. C., Zhang, J., Li, L., Chang, C. Y., Zhou, X. L., …, & Xie, W. F. (2023). Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China. Journal of Digestive Diseases, 24(2), 122-132. https://doi.org/10.1111/1751-2980.13171

Vancouver

Zeng X, Yin C, Sun CY, Lu CH, Zhao SS, Gao XH, et al. Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China. Journal of Digestive Diseases. 2023;24(2):122-132. doi:10.1111/1751-2980.13171

BibTeX
@article{Zeng2023,
  author = {Zeng, Xin and Yin, Chuan and Sun, Chun Yan and Lu, Cui Hua and Zhao, Shou Song and Gao, Xiao Hong and Chen, Dong Feng and Wen, Liang Zhi and Lin, Shi De and Yang, Ping and Zhang, Qian Hua and Guan, Yu Juan and Zhang, Yang and Ren, Shu Qin and Cai, Da Chuan and Zhang, Jie and Li, Lei and Chang, Cong Ying and Zhou, Xiao Lin and Shi, Pei Mei and Chen, Shi Yao and Lin, Yong and Xie, Wei Fen},
  title = {Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China},
  journal = {Journal of Digestive Diseases},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {122--132},
  doi = {10.1111/1751-2980.13171}
}
Kostenlos starten →